股本结构
单位:万股
| 公告日期 | 2023-09-29 | 2023-08-08 | 2023-08-08 | 2023-05-09 | 2023-04-28 | 2023-05-09 |
|---|---|---|---|---|---|---|
| 证券总股本 | 2705.08 | 2705.45 | 2705.84 | 2685.13 | 2686.50 | 2686.85 |
| 普通股本 | 2705.08 | 2705.45 | 2705.84 | 2685.13 | 2686.50 | 2686.85 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2023-09-28 | 2023-07-28 | 2023-06-30 | 2023-04-30 | 2023-04-17 | 2023-03-31 |
注释:中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本(万股) | 变动后优先股(万股) | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2023-09-29 | 2705.08 | 未披露 | 定期报告 | 2023-09-28 |
| 2023-08-08 | 2705.45 | 未披露 | 定期报告 | 2023-07-28 |
| 2023-08-08 | 2705.84 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Exercise of stock options, net of shares withheld
Issuance of restricted stock
|
2023-06-30 |
| 2023-05-09 | 2685.13 | 未披露 | 定期报告 | 2023-04-30 |
| 2023-04-28 | 2686.50 | 未披露 | 定期报告 | 2023-04-17 |
| 2023-05-09 | 2686.85 | 未披露 |
更多>>
From January 1, 2023 to March 31, 2023
Exercise of stock options, net of shares withheld
Issuance of restricted stock
|
2023-03-31 |
| 2023-03-10 | 2687.07 | 未披露 | 定期报告 | 2023-02-28 |
| 2023-03-10 | 2712.91 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Issuance of restricted stock
Exercise of stock options, net of shares withheld
Issuance of common stock awards
Vesting of restricted stock units
Shares withheld for payment of employee taxes
|
2022-12-31 |
| 2022-11-04 | 2712.43 | 未披露 | 定期报告 | 2022-10-15 |
| 2022-11-04 | 2708.14 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Shares withheld for payment of employee taxes
Forfeitures of restricted shares
Issuance of restricted stock
Exercise of stock options, net of shares withheld
Issuance of common stock awards
|
2022-09-30 |
| 2022-08-05 | 2625.10 | 未披露 | 定期报告 | 2022-07-29 |
| 2022-08-05 | 2626.02 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Issuance of common stock awards
Issuance of restricted stock
Exercise of stock options, net of shares withheld
Forfeitures of restricted shares
|
2022-06-30 |
| 2022-05-09 | 2584.93 | 未披露 | 定期报告 | 2022-04-30 |
| 2022-04-28 | 2585.19 | 未披露 | 定期报告 | 2022-04-18 |
| 2022-05-09 | 2585.31 | 未披露 |
更多>>
From January 1, 2022 to March 31, 2022
Issuance of common stock awards
Issuance of restricted stock
Exercise of stock options, net of shares withheld
|
2022-03-31 |
| 2022-02-25 | 2573.18 | 未披露 | 定期报告 | 2022-02-16 |
| 2022-02-25 | 2566.64 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of common stock awards
Issuance of restricted stock
Exercise of stock options, net of shares withheld
|
2021-12-31 |
| 2021-11-05 | 2571.87 | 未披露 | 定期报告 | 2021-10-31 |
| 2021-11-05 | 2503.23 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Issuance of restricted stock
Exercise of stock options, net of shares withheld
|
2021-09-30 |
| 2021-08-06 | 2502.29 | 未披露 | 定期报告 | 2021-07-26 |
| 2021-08-06 | 2502.29 | 未披露 |
更多>>
from March 31, 2021 to June 30, 2021
Issuance of restricted stock
Exercise of stock options, net of shares withheld
Forfeitures of restricted shares
|
2021-06-30 |
| 2021-05-07 | 2484.33 | 未披露 | 定期报告 | 2021-04-23 |
| 2021-04-29 | 2484.30 | 未披露 | 定期报告 | 2021-04-19 |
| 2021-05-07 | 2507.77 | 未披露 |
更多>>
From January 1, 2021 to March 31, 2021
Issuance of common stock awards
Issuance of restricted stock
Exercise of stock options, net of shares withheld
Forfeitures of restricted shares
|
2021-03-31 |
| 2021-02-26 | 2468.25 | 未披露 | 定期报告 | 2021-02-16 |
| 2021-02-26 | 2400.49 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Issuance of common stock in connection with acquisition
Issuance of common stock awards
Issuance of restricted stock
Exercise of stock options, net of shares withheld
Issuance of common stock in connection with the settlement of acquisition-related contingent consideration
Forfeitures of restricted shares
Share adjustment
|
2020-12-31 |
| 2020-11-06 | 2382.80 | 未披露 | 定期报告 | 2020-10-23 |
| 2020-11-06 | 2326.46 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Issuance of restricted stock
Exercise of stock options,net of shares withheld
Issuance of common stock in connection with the settlement of acquisition-related contingent consideration
Forfeitures of restricted shares
|
2020-09-30 |
| 2020-08-06 | 2296.04 | 未披露 | 定期报告 | 2020-07-24 |
| 2020-08-06 | 2295.53 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Issuance of restricted stock
Forfeitures of restricted shares
Exercise of stock options
|
2020-06-30 |
| 2020-05-08 | 2302.09 | 未披露 | 定期报告 | 2020-04-21 |
| 2020-05-08 | 2281.75 | 未披露 |
更多>>
From January 1, 2020 to March 31, 2020
Issuance of common stock awards
Issuance of restricted stock
Exercise of stock options
Forfeitures of restricted shares
Share adjustment
|
2020-03-31 |
| 2020-03-02 | 2238.16 | 未披露 | 定期报告 | 2020-02-15 |
| 2020-03-02 | 2232.13 | 未披露 |
更多>>
from December 31, 2018 to December 31, 2019
Issuance of common stock in connection with acquisition
Issuance of common stock awards
Issuance of restricted stock
Exercise of stock options
Issuance of common stock in connection with the settlement of acquisition-related contingent consideration
Exercise of stock options
|
2019-12-31 |
| 2019-11-08 | 2220.50 | 未披露 | 定期报告 | 2019-10-31 |
| 2019-11-08 | 2219.21 | 未披露 |
更多>>
from June 30, 2019 to September 30, 2019
Issuance of common stock awards
Exercise of stock options
|
2019-09-30 |
| 2019-08-09 | 2208.82 | 未披露 | 定期报告 | 2019-07-31 |
| 2019-08-09 | 2208.18 | 未披露 |
更多>>
From March 31, 2019 to June 30, 2019
Issuance of common stock awards
Issuance of restricted stock
Exercise of stock options
|
2019-06-30 |
| 2019-05-10 | 2198.83 | 未披露 | 定期报告 | 2019-04-30 |
| 2019-04-30 | 2198.50 | 未披露 | 定期报告 | 2019-04-23 |
| 2019-05-10 | 2197.82 | 未披露 |
更多>>
from January 1, 2019 to March 31, 2019
Issuance of common stock in connection with acquisition
Issuance of common stock awards
Issuance of restricted stock
Exercise of stock options
Issuance of common stock in connection with the settlement of acquisition-related contingent consideration
|
2019-03-31 |
| 2019-03-01 | 2112.86 | 未披露 | 定期报告 | 2019-02-25 |
| 2019-03-01 | 2055.75 | 未披露 |
更多>>
from December 31, 2017 to December 31, 2018
Forfeitures of restricted shares
Shares repurchased
Net exercise of stock options
Exercise of stock options
|
2018-12-31 |
| 2018-11-08 | 2046.59 | 未披露 | 定期报告 | 2018-10-31 |
| 2018-11-08 | 2035.66 | 未披露 |
更多>>
from January 1, 2018 to September 30, 2018
Issuance of common stock in connection with acquisition
Issuance of restricted stock
Net exercise of stock options
Exercise of stock options
|
2018-09-30 |
| 2018-08-08 | 2024.29 | 未披露 | 定期报告 | 2018-07-31 |
| 2018-08-08 | 2022.56 | 未披露 |
更多>>
from January 1, 2018 to June 30, 2018
Issuance of restricted stock
Net exercise of stock options
Exercise of stock options
Shares surrendered by stockholder
Shares repurchased
|
2018-06-30 |
| 2018-05-09 | 2000.61 | 未披露 | 定期报告 | 2018-04-30 |
| 2018-05-01 | 2000.54 | 未披露 | 定期报告 | 2018-04-24 |
| 2018-05-09 | 2014.12 | 未披露 |
更多>>
from January 1, 2018 to March 31, 2018
Issuance of restricted stock
Net exercise of stock options
Exercise of stock options
Shares surrendered by stockholder
Shares repurchased
|
2018-03-31 |
| 2018-03-14 | 2001.35 | 未披露 | 定期报告 | 2018-02-28 |
| 2018-03-14 | 1929.75 | 未披露 |
更多>>
from December 31, 2016 to December 31, 2017
Issuance of common stock, net of issuance costs
Issuance of common stock in connection with acquisition
Issuance of restricted stock
Shares surrendered by stockholder
Net exercise of stock warrants
Net exercise of stock options
Exercise of stock options
|
2017-12-31 |
| 2017-11-09 | 1784.90 | 未披露 | 定期报告 | 2017-10-31 |
| 2017-11-09 | 1783.19 | 未披露 |
更多>>
From January 1, 2017 to September 30, 2017
Issuance of common stock in connection with acquisition
Issuance of restricted stock
Shares surrendered by stockholder
Shares repurchased
Net exercise of stock warrants
Net exercise of stock options
Exercise of stock options
|
2017-09-30 |
| 2017-08-08 | 1736.02 | 未披露 | 定期报告 | 2017-07-31 |
| 2017-08-08 | 1728.68 | 未披露 |
更多>>
From January 1, 2017 to June 30, 2017
Issuance of restricted stock
Shares surrendered by stockholder
Net exercise of stock warrants
Net exercise of stock options
Exercise of stock options
Shares repurchased
|
2017-06-30 |
| 2017-05-02 | 1721.82 | 未披露 | 定期报告 | 2017-04-15 |
| 2017-05-02 | 1709.71 | 未披露 |
更多>>
from January 1, 2017 to March 31, 2017
Issuance of restricted stock
Shares surrendered by stockholder
Net exercise of stock options
Exercise of stock options
|
2017-03-31 |
| 2017-03-14 | 1707.31 | 未披露 | 定期报告 | 2017-02-28 |
| 2017-03-14 | 1662.85 | 未披露 |
更多>>
from December 31, 2015 to December 31, 2016
Conversion of redeemable convertible preferred stock upon initial public offering
Issuance of common stock in connection with satisfaction of contingent consideration related to acquisition of St. Mary's Prescription Pharmacy
Transfer of common stock
Issuance of common stock
Issuance of restricted stock
Redesignation of Class A and Class B common stock upon initial public offering
Net exercise of stock warrants
Net exercise of stock options
Issuance of common stock upon initial public offering, net of issuance costs
Surrender of common stock
Issuance of common stock in connection with Leadership Exit Bonus Plan
Shares withheld for tax in connection with Leadership Exit Bonus Plan
Issuance of common stock in connection with satisfaction of acquisition consideration related to asset acquisition of 9176-1916 Quebec, Inc.
Exercise of stock options
The Company effected a 1-for-1.94 reverse split of its common stock on September 16, 2016.
|
2016-12-31 |
| 2016-11-10 | 1610.12 | 未披露 | 定期报告 | 2016-10-31 |
| 2016-11-10 | 558.34 | 987.35 |
更多>>
From January 1, 2016 to September 30, 2016
Issuance of common stock in connection with satisfaction of contingent consideration related to acquisition of St. Mary's Prescription Pharmacy
Transfer of common stock
Issuance of common stock
Net exercise of stock warrants
Net exercise of stock options
Issuance of restricted stock
|
2016-09-30 |
| 2016-09-29 | 1558.46 | 未披露 |
更多>>
The Company effected a 1-for-1.94 reverse split of its common stock on September 16, 2016. The reverse split combined each 1.94 shares of the Company's issued and outstanding common stock into one share of common stock and correspondingly adjusted the conversion prices of its convertible preferred stock. No fractional shares were issued in connection with the reverse split. Any fractional shares resulting from the reverse split were rounded down to the nearest whole share and in lieu of any fractional shares the Company will pay a cash amount to the holder of such fractional share equal to the fair market value of such fractional share as determined by the Board.
|
2016-09-29 |
| 2016-09-19 | 486.08 | 987.35 |
更多>>
From January 1, 2016 to June 30, 2016
Issuance of common stock in connection with satisfaction of contingent consideration related to acquisition of St. Mary's Prescription Pharmacy
Transfer of common stock
Issuance of common stock
Net exercise of stock warrants
Net exercise of stock options
The Company effected a 1-for-1.94 reverse split of its common stock on September 16, 2016. The reverse split combined each 1.94 shares of the Company's issued and outstanding common stock into one share of common stock and correspondingly adjusted the conversion prices of its convertible preferred stock. No fractional shares were issued in connection with the reverse split. Any fractional shares resulting from the reverse split were rounded down to the nearest whole share and in lieu of any fractional shares the Company will pay a cash amount to the holder of such fractional share equal to the fair market value of such fractional share as determined by the Board.
|
2016-06-30 |
| 2016-07-21 | 943.00 | 987.35 |
更多>>
From January 1,2016 to March 31, 2016
Issuance of common stock in connection with satisfaction of contingent consideration related to acquisition of St. Mary Prescription Pharmacy
Transfer of common stock
Net exercise of stock warrants
Net exercise of stock options
|
2016-03-31 |
| 2016-01-04 | 887.12 | 987.35 |
更多>>
from January 1, 2015 to September 30, 2015
Issuance of common stock in connection with satisfaction of contingent consideration related to acquisition of St. Mary Prescription Pharmacy
Issuance of common stock in connection with satisfaction of contingent consideration related to acquisition of Capstone Performance Systems, LLC
Transfer of common stock
Exercise of stock options
|
2015-09-30 |
From March 31, 2023 to June 30, 2023
Exercise of stock options, net of shares withheld
Issuance of restricted stock
From January 1, 2023 to March 31, 2023
Exercise of stock options, net of shares withheld
Issuance of restricted stock
From December 31, 2021 to December 31, 2022
Issuance of restricted stock
Exercise of stock options, net of shares withheld
Issuance of common stock awards
Vesting of restricted stock units
Shares withheld for payment of employee taxes
From June 30, 2022 to September 30, 2022
Shares withheld for payment of employee taxes
Forfeitures of restricted shares
Issuance of restricted stock
Exercise of stock options, net of shares withheld
Issuance of common stock awards
From March 31, 2022 to June 30, 2022
Issuance of common stock awards
Issuance of restricted stock
Exercise of stock options, net of shares withheld
Forfeitures of restricted shares
From January 1, 2022 to March 31, 2022
Issuance of common stock awards
Issuance of restricted stock
Exercise of stock options, net of shares withheld
From December 31, 2020 to December 31, 2021
Issuance of common stock awards
Issuance of restricted stock
Exercise of stock options, net of shares withheld
From June 30, 2021 to September 30, 2021
Issuance of restricted stock
Exercise of stock options, net of shares withheld
from March 31, 2021 to June 30, 2021
Issuance of restricted stock
Exercise of stock options, net of shares withheld
Forfeitures of restricted shares
From January 1, 2021 to March 31, 2021
Issuance of common stock awards
Issuance of restricted stock
Exercise of stock options, net of shares withheld
Forfeitures of restricted shares
From December 31, 2019 to December 31, 2020
Issuance of common stock in connection with acquisition
Issuance of common stock awards
Issuance of restricted stock
Exercise of stock options, net of shares withheld
Issuance of common stock in connection with the settlement of acquisition-related contingent consideration
Forfeitures of restricted shares
Share adjustment
From June 30, 2020 to September 30, 2020
Issuance of restricted stock
Exercise of stock options,net of shares withheld
Issuance of common stock in connection with the settlement of acquisition-related contingent consideration
Forfeitures of restricted shares
From March 31, 2020 to June 30, 2020
Issuance of restricted stock
Forfeitures of restricted shares
Exercise of stock options
From January 1, 2020 to March 31, 2020
Issuance of common stock awards
Issuance of restricted stock
Exercise of stock options
Forfeitures of restricted shares
Share adjustment
from December 31, 2018 to December 31, 2019
Issuance of common stock in connection with acquisition
Issuance of common stock awards
Issuance of restricted stock
Exercise of stock options
Issuance of common stock in connection with the settlement of acquisition-related contingent consideration
Exercise of stock options
from June 30, 2019 to September 30, 2019
Issuance of common stock awards
Exercise of stock options
From March 31, 2019 to June 30, 2019
Issuance of common stock awards
Issuance of restricted stock
Exercise of stock options
from January 1, 2019 to March 31, 2019
Issuance of common stock in connection with acquisition
Issuance of common stock awards
Issuance of restricted stock
Exercise of stock options
Issuance of common stock in connection with the settlement of acquisition-related contingent consideration
from December 31, 2017 to December 31, 2018
Forfeitures of restricted shares
Shares repurchased
Net exercise of stock options
Exercise of stock options
from January 1, 2018 to September 30, 2018
Issuance of common stock in connection with acquisition
Issuance of restricted stock
Net exercise of stock options
Exercise of stock options
from January 1, 2018 to June 30, 2018
Issuance of restricted stock
Net exercise of stock options
Exercise of stock options
Shares surrendered by stockholder
Shares repurchased
from January 1, 2018 to March 31, 2018
Issuance of restricted stock
Net exercise of stock options
Exercise of stock options
Shares surrendered by stockholder
Shares repurchased
from December 31, 2016 to December 31, 2017
Issuance of common stock, net of issuance costs
Issuance of common stock in connection with acquisition
Issuance of restricted stock
Shares surrendered by stockholder
Net exercise of stock warrants
Net exercise of stock options
Exercise of stock options
From January 1, 2017 to September 30, 2017
Issuance of common stock in connection with acquisition
Issuance of restricted stock
Shares surrendered by stockholder
Shares repurchased
Net exercise of stock warrants
Net exercise of stock options
Exercise of stock options
From January 1, 2017 to June 30, 2017
Issuance of restricted stock
Shares surrendered by stockholder
Net exercise of stock warrants
Net exercise of stock options
Exercise of stock options
Shares repurchased
from January 1, 2017 to March 31, 2017
Issuance of restricted stock
Shares surrendered by stockholder
Net exercise of stock options
Exercise of stock options
from December 31, 2015 to December 31, 2016
Conversion of redeemable convertible preferred stock upon initial public offering
Issuance of common stock in connection with satisfaction of contingent consideration related to acquisition of St. Mary's Prescription Pharmacy
Transfer of common stock
Issuance of common stock
Issuance of restricted stock
Redesignation of Class A and Class B common stock upon initial public offering
Net exercise of stock warrants
Net exercise of stock options
Issuance of common stock upon initial public offering, net of issuance costs
Surrender of common stock
Issuance of common stock in connection with Leadership Exit Bonus Plan
Shares withheld for tax in connection with Leadership Exit Bonus Plan
Issuance of common stock in connection with satisfaction of acquisition consideration related to asset acquisition of 9176-1916 Quebec, Inc.
Exercise of stock options
The Company effected a 1-for-1.94 reverse split of its common stock on September 16, 2016.
From January 1, 2016 to September 30, 2016
Issuance of common stock in connection with satisfaction of contingent consideration related to acquisition of St. Mary's Prescription Pharmacy
Transfer of common stock
Issuance of common stock
Net exercise of stock warrants
Net exercise of stock options
Issuance of restricted stock
The Company effected a 1-for-1.94 reverse split of its common stock on September 16, 2016. The reverse split combined each 1.94 shares of the Company's issued and outstanding common stock into one share of common stock and correspondingly adjusted the conversion prices of its convertible preferred stock. No fractional shares were issued in connection with the reverse split. Any fractional shares resulting from the reverse split were rounded down to the nearest whole share and in lieu of any fractional shares the Company will pay a cash amount to the holder of such fractional share equal to the fair market value of such fractional share as determined by the Board.
From January 1, 2016 to June 30, 2016
Issuance of common stock in connection with satisfaction of contingent consideration related to acquisition of St. Mary's Prescription Pharmacy
Transfer of common stock
Issuance of common stock
Net exercise of stock warrants
Net exercise of stock options
The Company effected a 1-for-1.94 reverse split of its common stock on September 16, 2016. The reverse split combined each 1.94 shares of the Company's issued and outstanding common stock into one share of common stock and correspondingly adjusted the conversion prices of its convertible preferred stock. No fractional shares were issued in connection with the reverse split. Any fractional shares resulting from the reverse split were rounded down to the nearest whole share and in lieu of any fractional shares the Company will pay a cash amount to the holder of such fractional share equal to the fair market value of such fractional share as determined by the Board.
From January 1,2016 to March 31, 2016
Issuance of common stock in connection with satisfaction of contingent consideration related to acquisition of St. Mary Prescription Pharmacy
Transfer of common stock
Net exercise of stock warrants
Net exercise of stock options
from January 1, 2015 to September 30, 2015
Issuance of common stock in connection with satisfaction of contingent consideration related to acquisition of St. Mary Prescription Pharmacy
Issuance of common stock in connection with satisfaction of contingent consideration related to acquisition of Capstone Performance Systems, LLC
Transfer of common stock
Exercise of stock options